Skip to main content
Skip to main content
BAD logo

B.A.D. ETF (BAD) Stock Analysis

$11.91 +$0.00 (+0.00%) |CouncilSplit View · 46 · C
Bottom line: Split View — our Council read (46/100) and AI Score (44/100) broadly agree. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.
MCap: $9.53M| Vol: 148|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

B.A.D. ETF (BAD) trades at $11.91 with AI Score 44/100 (Grade C). B. A. D. Market cap: $9.53M, Sector: Financial services.

Price as of Jul 21, 2026 · Last analyzed: Mar 17, 2026
B.A.D. ETF is a passively managed fund that tracks a rules-based index, providing exposure to betting, alcohol, Canadian cannabis, and pharmaceutical companies. The fund is non-diversified and aims to mirror the index's performance before fees and expenses.

Analyst Coverage for BAD: BAD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BAD against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the BAD film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 46/100 · C

BAD: the 3 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Neutral
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

B.A.D. ETF (BAD) Financial Services Profile

IPO Year2021

B.A.D. ETF offers targeted exposure to specific sectors, including betting, alcohol, Canadian cannabis, and pharmaceuticals, through a passive indexing strategy. As a non-diversified fund, it aims to replicate the performance of its underlying index, appealing to investors seeking concentrated exposure to these industries.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 17, 2026

What Is the Investment Thesis for BAD?

As of Mar 17, 2026 — figures reflect the data available on that date.

B.A.D. ETF presents a targeted investment vehicle for those seeking exposure to the betting, alcohol, cannabis, and pharmaceutical sectors. The fund's passive management approach aims to replicate the performance of its underlying index, offering a cost-effective way to invest in these industries. Key value drivers include the growth potential of the cannabis market, the resilience of the alcohol and pharmaceutical sectors, and the expansion of legalized betting and gambling. However, investors should be aware of the risks associated with the fund's non-diversified nature, which makes it susceptible to sector-specific downturns and regulatory changes. The ETF's performance is directly tied to the performance of the companies within its index, making it crucial to monitor the trends and developments within these industries.

Based on FMP financials and quantitative analysis

BAD Key Highlights

  • B.A.D. ETF focuses on a niche investment strategy, targeting betting, alcohol, cannabis, and pharmaceutical sectors.
  • The fund operates with a passive management approach, aiming to replicate the performance of its underlying index.
  • B.A.D. ETF is non-diversified, concentrating its investments in specific sectors, which can lead to higher volatility.
  • The fund's performance is directly linked to the growth and regulatory landscape of the betting, alcohol, cannabis, and pharmaceutical industries.
  • B.A.D. ETF offers investors a simplified way to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks.

Who Are BAD's Competitors?

BAD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ERM EquityCompass Risk Manager ETF $23.09 -0.17% $8.67M 44
GERM ETFMG Treatments, Testing and Advancements ETF $19.16 -0.29% $9.59M 44
GFOF Grayscale Future of Finance ETF $27.69 +0.09% $10.4M 44
GPOW Goldman Sachs North American Pipelines & Power Equity ETF $53.96 -1.00% $10.5M 44
HART NYLI Healthy Hearts ETF $30.67 +0.32% $8.66M 44
ALTEX Firsthand Alternative Energy Fund $13.22 -1.86% $9.18M 82
FB ProShares - S&P 500 Dynamic Buffer ETF $44.60 +0.09% $8.38M 66
TTT ProShares - UltraPro Short 20+ Year Treasury $72.52 +0.74% $18.4M 67

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are BAD's Key Strengths?

  • Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals).
  • Passive management approach.
  • Rules-based index.
  • Simplified way to gain exposure to a basket of companies within these sectors.

What Are BAD's Weaknesses?

  • Non-diversified nature.
  • Susceptibility to sector-specific downturns.
  • Reliance on regulatory landscape.
  • Potential for high volatility.

What Could Drive BAD Stock Higher?

  • Further legalization of cannabis in additional states and countries.
  • Expansion of online betting and gambling markets.
  • Pharmaceutical companies within the fund achieving FDA approvals for new drugs.

What Are the Key Risks for BAD?

  • Regulatory changes negatively impacting the betting, alcohol, cannabis, and pharmaceutical industries.
  • Economic downturns reducing consumer spending on these products.
  • High volatility due to the fund's non-diversified nature.
  • Negative sentiment towards specific sectors affecting investor demand.

What Are the Growth Opportunities for BAD?

  • Expansion of Legalized Betting and Gambling: The ongoing legalization of sports betting and online gambling in various jurisdictions presents a significant growth opportunity for B.A.D. ETF. As more states and countries legalize these activities, the companies within the ETF's betting and gambling sector are likely to experience increased revenue and profitability. This trend is expected to continue over the next 3-5 years, driving growth for the ETF. The global online gambling market is projected to reach $127.3 billion by 2027, according to a report by Allied Market Research.
  • Growth of the Cannabis Market: The increasing legalization and acceptance of cannabis for both medical and recreational purposes is a major growth driver for B.A.D. ETF. The ETF's exposure to Canadian cannabis companies allows it to capitalize on the expanding cannabis market. As more countries and regions legalize cannabis, the companies within the ETF's portfolio are expected to benefit from increased demand and market opportunities. The global legal cannabis market is projected to reach $90.4 billion by 2026, according to a report by Grand View Research.
  • Resilience of the Alcohol Sector: The alcohol industry is known for its resilience, even during economic downturns. B.A.D. ETF's exposure to alcohol companies provides a stable source of revenue and growth potential. The demand for alcoholic beverages remains consistent, making this sector a reliable component of the ETF's portfolio. The global alcoholic beverages market is projected to reach $1.6 trillion by 2025, according to a report by Statista.
  • Pharmaceutical Sector Innovation: The pharmaceutical industry is constantly innovating, with new drugs and therapies being developed to address various health conditions. B.A.D. ETF's exposure to pharmaceutical companies allows it to benefit from these advancements. The development and commercialization of new drugs can drive significant revenue growth for the companies within the ETF's portfolio. The global pharmaceutical market is projected to reach $1.57 trillion by 2028, according to a report by Fortune Business Insights.
  • Increased Investor Demand for Thematic ETFs: The growing popularity of thematic ETFs, which focus on specific sectors or trends, presents a growth opportunity for B.A.D. ETF. Investors are increasingly seeking targeted exposure to specific areas of the market, and thematic ETFs provide a convenient way to achieve this. As more investors allocate capital to thematic ETFs, B.A.D. ETF is likely to benefit from increased inflows and asset growth. The global thematic ETF market is projected to reach $400 billion by 2027, according to a report by ETFGI.

What Opportunities Does BAD Have?

  • Expansion of legalized betting and gambling.
  • Growth of the cannabis market.
  • Pharmaceutical sector innovation.
  • Increased investor demand for thematic ETFs.

What Threats Does BAD Face?

  • Regulatory changes in betting, alcohol, cannabis, and pharmaceutical sectors.
  • Economic downturns affecting consumer spending on these products.
  • Increased competition from other thematic ETFs.
  • Negative sentiment towards specific sectors.

What Are BAD's Competitive Advantages?

  • First-mover advantage in offering a unique combination of sector exposure.
  • Passive management approach provides cost-effectiveness.
  • Rules-based index ensures transparency and consistency.

What Does BAD Do?

B.A.D. ETF operates as a passively managed fund, designed to replicate the performance of a specific rules-based index. The fund's investment strategy focuses on providing exposure to a unique combination of sectors: betting or gambling companies, alcohol companies, Canadian cannabis companies (defined as those listed on Canadian exchanges, domiciled in Canada, or primarily operating there), and pharmaceutical companies. By tracking this index, B.A.D. ETF aims to deliver returns that mirror the collective performance of these industries, before accounting for fees and expenses. The fund's non-diversified nature means that its performance is heavily reliant on the performance of these specific sectors, making it a targeted investment vehicle for those with a particular interest in these areas. The fund's structure allows investors to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks, offering a simplified approach to investing in these industries.

What Products and Services Does BAD Offer?

  • Tracks a rules-based index focused on betting, alcohol, cannabis, and pharmaceutical companies.
  • Provides exposure to a portfolio of companies in specific sectors.
  • Offers a passive management approach, aiming to replicate the index's performance.
  • Invests in companies listed on Canadian exchanges, domiciled in Canada, or primarily operating in Canada within the cannabis sector.
  • Offers investors a simplified way to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks.
  • Operates as a non-diversified fund, concentrating its investments in specific sectors.

How Does BAD Make Money?

  • Generates revenue through management fees charged to investors.
  • Aims to replicate the performance of its underlying index, providing returns to investors.
  • Attracts investors seeking targeted exposure to betting, alcohol, cannabis, and pharmaceutical sectors.

What Industry Does BAD Operate In?

B.A.D. ETF operates within the asset management industry, specifically focusing on thematic ETFs that target niche sectors. The ETF's strategy of investing in betting, alcohol, cannabis, and pharmaceutical companies positions it within industries experiencing varying degrees of growth and regulatory scrutiny. The competitive landscape includes other thematic ETFs, such as ERM, GERM, GFOF, GPOW, and HART, that may focus on similar or overlapping sectors. The asset management industry is characterized by increasing demand for specialized investment products, driven by investors seeking targeted exposure to specific market trends and sectors.

Who Are BAD's Key Customers?

  • Retail investors seeking exposure to specific sectors.
  • Institutional investors looking for targeted investment strategies.
  • Investors interested in the betting, alcohol, cannabis, and pharmaceutical industries.
AI Confidence: 71% Updated: Mar 17, 2026

B.A.D. ETF (BAD) Valuation Context

Relative to its peer group, BAD's quantitative score of 44/100 is roughly in line with the peer average of 44/100.

BAD Financials

Bull Case vs Bear Case

Bull Case

  • Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals).
  • Passive management approach.
  • Rules-based index.
  • Simplified way to gain exposure to a basket of companies within these sectors.

Bear Case

  • Non-diversified nature.
  • Susceptibility to sector-specific downturns.
  • Reliance on regulatory landscape.
  • Potential for high volatility.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

BAD Latest News

No recent news available for BAD.

BAD Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BAD.

Price Targets

Wall Street price target analysis for BAD.

BAD MoonshotScore

44/100

What does this score mean?

The MoonshotScore rates BAD 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

What Investors Ask About B.A.D. ETF (BAD) — Financial Services

What does the AI Score mean for BAD?

BAD holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. B.A.D. ETF is a passively managed fund that tracks a rules-based index, providing exposure to betting, alcohol, Canadian cannabis, and pharmaceutical companies. The fund is non-diversified and aims …

What does B.A.D. ETF do?

B.A.D. ETF is a passively managed fund that tracks a rules-based index, providing exposure to a portfolio of companies in the betting, alcohol, Canadian cannabis, and pharmaceutical sectors. The fund aims to replicate the performance of its underlying index, offering investors a simplified way to gain exposure to these industries without directly purchasing individual stocks.

What are the main risks for BAD?

The main risks for B.A.D. ETF stem from its non-diversified nature and its focus on specific sectors. Regulatory changes in the betting, alcohol, cannabis, and pharmaceutical industries could significantly impact the fund's performance. Economic downturns could reduce consumer spending on these products, leading to decreased revenue for the companies within the ETF's portfolio.

What are the key factors to evaluate for BAD?

B.A.D. ETF (BAD) holds an AI score of 44/100 (low). Not financial advice.

How frequently does BAD data refresh on this page?

BAD's price was last updated on Jul 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven BAD's recent stock price performance?

B.A.D. ETF (BAD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals). See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BAD overvalued or undervalued right now?

B.A.D. ETF (BAD) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research BAD before investing?

Before investing in B.A.D. ETF (BAD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding BAD to a portfolio?

Key strength of B.A.D. ETF (BAD): Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals). Weigh rewards against risks and diversify. Not financial advice.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The fund's performance is heavily reliant on the performance of the specific sectors it targets.
  • Regulatory changes in the betting, alcohol, cannabis, and pharmaceutical industries could significantly impact the fund's performance.
Data Sources

Popular Stocks